DGAP-News: M1 Kliniken AG / Key word(s): Expansion
07.08.2019 / 09:30
The issuer is solely responsible for the content of this announcement.
M1 Kliniken AG: Market leader in the field of beauty medicine in Germany creates basis for further growth at home and abroad
– Capacity expansion to increase output in Germany
– Specialist centres opened in Australia and the Netherlands
– Market entry in Switzerland and Great Britain within 2019
Berlin, 07.08.2019 – After M1 Kliniken AG (ISIN: DE000A0STSQ8) was able to increase the number of specialist centres from 17 to 24 by the end of the year in 2018, the Group has created the prerequisites for further growth in Germany and abroad in recent months.
In Germany, the expansion of room capacities created the basis for a significantly larger number of doctors in aesthetic medicine. These facilities are now to be used successively and contribute to M1’s further sales growth.
The company is also pushing ahead with international expansion in the current year. Following the opening of the first “M1 Med Beauty” specialist centre for aesthetic medicine outside its home market in Vienna in December 2018, new specialist centres have been opened in the Netherlands (Amsterdam) and Australia (Melbourne). Further specialist centres are to follow in both countries in the current year. In addition, market entry in Great Britain and Switzerland is imminent. The total number of specialist centres outside Germany is to rise to around 20 by the end of 2020. International business will thus increasingly become the Group’s second growth driver alongside Germany. M1 has already secured financing for its growth strategy through a capital increase in September 2018.
“We are well on track for positioning M1 as Europe’s number 1 in the growth market of beauty medicine,” says Patrick Brenske, CEO of M1 Kliniken AG. “In practically all Western European countries, the markets for beauty medicine are highly fragmented and high-priced. These are the best prerequisites for quickly rolling out our established and proven business model in Germany”.
M1 success model: high treatment quality at low costs at the same time
About M1 Kliniken AG
07.08.2019 Dissemination of a Corporate News, transmitted by DGAP – a service of EQS Group AG.
The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
|Company:||M1 Kliniken AG|
|Grünauer Straße 5|
|Phone:||+49 (0)30 347 47 44 14|
|Fax:||+49 (0)30 347 47 44 17|
|Listed:||Regulated Unofficial Market in Berlin, Dusseldorf, Frankfurt (Basic Board), Stuttgart, Tradegate Exchange|
|EQS News ID:||853213|
|End of News||DGAP News Service|